Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical study initiated at Massachusetts General...
SUWON, Republic of Korea, Feb. 07, 2022 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi...
MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on acquiring,...
JUPITER, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology...
Call to be held on Monday, February 14th at 1:00 PM Eastern TimeLAVAL, Quebec, Feb. 07, 2022 (GLOBE NEWSWIRE) --...
Orthopaedic Research and Education Foundation (OREF) Clinical Research Award Presented to Miach Founder Dr. Martha Murray and Colleagues WESTBOROUGH, Mass.--(BUSINESS...
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced that ClearUP®...
New Innovations Provide a More Complete and Accurate View of Patient Medication History, Driving Improvements in Workflow Efficiency and Medication...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its...